The chronic and acute pain clinical trial analysis report delivers important insights into ongoing research of 200+ pipeline chronic and acute pain drugs, clinical strategies, upcoming therapeutics, ...

Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst research report was published on the Company that explains ...

There are currently dozens of clinical trials examining new ways to treat mantle cell lymphoma (MCL). People can learn about trial recruitment at ClinicalTrials.gov. Research into mantle cell lymphoma ...

CURE spoke with Dr. Robert Alter of John Theurer Cancer Center about the best time to explore clinical trials. For patients ...

Would a placebo make cancer worse? Will I know if I am given a placebo in a clinical trial? Get answers to your pressing ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...

Prospective FORESEE trial of CNSide Cerebrospinal Fluid (CSF) Assay met key primary and secondary endpoints CNSide CSF Assay influenced clinical management decisions in over 90% of leptomeningeal ...

AUSTIN, Texas, Nov. 22, 2024 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Plus Therapeutics, Inc. (PSTV) (Nasdaq: PSTV) (“Plus” or the “Company”), will present data from ...

CNSide Diagnostics will present data from the FORESEE trial showcasing the CNSide CSF Assay Platform’s utility in diagnosing and guiding clinical decision making for breast cancer and non-small cell ...